Comments
Loading...
SI-BONE Analyst Ratings and Price Targets | NASDAQ:SIBN | Benzinga
SI-BONE Inc has a consensus price target of $24.82 based on the ratings of 11 analysts. The high is $32 issued by Citizens Capital Markets on February 25, 2025. The low is $19 issued by Morgan Stanley on August 6, 2024. The 3 most-recent analyst ratings were released by Citizens Capital Markets, Truist Securities, and Cantor Fitzgerald on February 25, 2025, respectively. With an average price target of $26.33 between Citizens Capital Markets, Truist Securities, and Cantor Fitzgerald, there's an implied 89.18% upside for SI-BONE Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Citizens Capital Markets
Truist Securities
Cantor Fitzgerald
Needham
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for SI-BONE
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/25/2025 | Buy Now | 129.89% | Citizens Capital Markets | David Turkaly52% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/25/2025 | Buy Now | 58.05% | Truist Securities | Samuel Brodovsky39% | $18 → $22 | Reiterates | Buy → Buy | Get Alert |
| 02/25/2025 | Buy Now | 79.6% | Cantor Fitzgerald | Ross Osborn46% | $25 → $25 | Reiterates | Overweight → Overweight | Get Alert |
| 02/25/2025 | Buy Now | 72.41% | Needham | David Saxon54% | $20 → $24 | Maintains | Buy | Get Alert |
| 01/13/2025 | Buy Now | 36.49% | Needham | David Saxon54% | $19 → $19 | Reiterates | Buy → Buy | Get Alert |
| 11/20/2024 | Buy Now | 36.49% | Needham | David Saxon54% | $19 → $19 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | 29.31% | Truist Securities | Samuel Brodovsky39% | $16 → $18 | Maintains | Buy | Get Alert |
| 11/13/2024 | Buy Now | 36.49% | Needham | David Saxon54% | $19 → $19 | Reiterates | Buy → Buy | Get Alert |
| 10/14/2024 | Buy Now | 14.94% | Truist Securities | Samuel Brodovsky39% | $18 → $16 | Maintains | Buy | Get Alert |
| 08/06/2024 | Buy Now | 36.49% | Morgan Stanley | Drew Ranieri45% | $21 → $19 | Maintains | Overweight | Get Alert |
| 08/06/2024 | Buy Now | 29.31% | Truist Securities | Samuel Brodovsky39% | $20 → $18 | Maintains | Buy | Get Alert |
| 08/06/2024 | Buy Now | 36.49% | Needham | David Saxon54% | $27 → $19 | Maintains | Buy | Get Alert |
| 07/15/2024 | Buy Now | 50.86% | Morgan Stanley | Drew Ranieri45% | $25 → $21 | Maintains | Overweight | Get Alert |
| 05/07/2024 | Buy Now | 129.89% | JMP Securities | David Turkaly52% | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/07/2024 | Buy Now | 93.97% | Needham | David Saxon54% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | Buy Now | 79.6% | Morgan Stanley | Drew Ranieri45% | $26 → $25 | Maintains | Overweight | Get Alert |
| 04/03/2024 | Buy Now | 93.97% | Needham | David Saxon54% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
| 03/28/2024 | Buy Now | 79.6% | Piper Sandler | Matt O'Brien51% | → $25 | Initiates | → Overweight | Get Alert |
| 02/27/2024 | Buy Now | 86.78% | Morgan Stanley | Drew Ranieri45% | $25 → $26 | Maintains | Overweight | Get Alert |
| 02/27/2024 | Buy Now | 79.6% | Cantor Fitzgerald | Ross Osborn46% | $25 → $25 | Maintains | Overweight | Get Alert |
| 02/27/2024 | Buy Now | 72.41% | Truist Securities | Samuel Brodovsky39% | $26 → $24 | Reiterates | Buy → Buy | Get Alert |
| 12/22/2023 | Buy Now | 86.78% | Truist Securities | David Rescott63% | $25 → $26 | Maintains | Buy | Get Alert |
| 12/04/2023 | Buy Now | 79.6% | Needham | David Saxon54% | → $25 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2023 | Buy Now | 79.6% | Cantor Fitzgerald | Ross Osborn46% | $30 → $25 | Maintains | Overweight | Get Alert |
| 11/07/2023 | Buy Now | 79.6% | Morgan Stanley | Drew Ranieri45% | $30 → $25 | Maintains | Overweight | Get Alert |
| 11/07/2023 | Buy Now | 79.6% | Needham | David Saxon54% | $32 → $25 | Maintains | Buy | Get Alert |
| 09/26/2023 | Buy Now | 115.52% | Cantor Fitzgerald | Ross Osborn46% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | Buy Now | 115.52% | Cantor Fitzgerald | Ross Osborn46% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 08/09/2023 | Buy Now | 115.52% | Cantor Fitzgerald | Ross Osborn46% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 08/08/2023 | Buy Now | 122.7% | Truist Securities | David Rescott63% | $33 → $31 | Maintains | Buy | Get Alert |
| 08/08/2023 | Buy Now | 129.89% | Needham | David Saxon54% | → $32 | Reiterates | Buy → Buy | Get Alert |
| 07/19/2023 | Buy Now | 137.07% | Truist Securities | David Rescott63% | $28 → $33 | Maintains | Buy | Get Alert |
| 07/12/2023 | Buy Now | 129.89% | Needham | David Saxon54% | $27 → $32 | Maintains | Buy | Get Alert |
| 05/31/2023 | Buy Now | 115.52% | Morgan Stanley | Drew Ranieri45% | $27 → $30 | Maintains | Overweight | Get Alert |
| 05/02/2023 | Buy Now | 115.52% | Cantor Fitzgerald | Ross Osborn46% | $24 → $30 | Maintains | Overweight | Get Alert |
| 05/02/2023 | Buy Now | 93.97% | Morgan Stanley | Drew Ranieri45% | $22 → $27 | Maintains | Overweight | Get Alert |
| 05/02/2023 | Buy Now | 129.89% | JMP Securities | David Turkaly52% | → $32 | Reiterates | → Market Outperform | Get Alert |
| 05/02/2023 | Buy Now | 93.97% | Canaccord Genuity | Kyle Rose64% | $24 → $27 | Maintains | Buy | Get Alert |
| 05/02/2023 | Buy Now | 93.97% | Needham | David Saxon54% | $24 → $27 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | 86.78% | Truist Securities | David Rescott63% | $21 → $26 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | 72.41% | Cantor Fitzgerald | Ross Osborn46% | $22 → $24 | Maintains | Overweight | Get Alert |
| 02/28/2023 | Buy Now | 72.41% | Canaccord Genuity | Kyle Rose64% | $21 → $24 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | 58.05% | Morgan Stanley | Drew Ranieri45% | $18 → $22 | Maintains | Overweight | Get Alert |
| 02/28/2023 | Buy Now | 72.41% | Needham | David Saxon54% | $20 → $24 | Maintains | Buy | Get Alert |
| 01/31/2023 | Buy Now | 50.86% | Truist Securities | Richard Newitter74% | $17 → $21 | Maintains | Buy | Get Alert |
| 01/06/2023 | Buy Now | 29.31% | Morgan Stanley | Drew Ranieri45% | $21 → $18 | Maintains | Overweight | Get Alert |
| 12/20/2022 | Buy Now | 22.13% | Truist Securities | David Rescott63% | $20 → $17 | Maintains | Buy | Get Alert |
| 11/08/2022 | Buy Now | 50.86% | Morgan Stanley | Drew Ranieri45% | $22 → $21 | Maintains | Overweight | Get Alert |
| 11/08/2022 | Buy Now | 129.89% | JMP Securities | David Turkaly52% | $36 → $32 | Maintains | Market Outperform | Get Alert |
| 11/08/2022 | Buy Now | 58.05% | Needham | David Saxon54% | $24 → $22 | Maintains | Buy | Get Alert |
| 10/12/2022 | Buy Now | 43.68% | Jefferies | Matthew Taylor70% | → $20 | Initiates | → Buy | Get Alert |
| 10/11/2022 | Buy Now | 58.05% | Morgan Stanley | Drew Ranieri45% | $21 → $22 | Maintains | Overweight | Get Alert |
| 08/09/2022 | Buy Now | 50.86% | Morgan Stanley | Drew Ranieri45% | $18 → $21 | Maintains | Overweight | Get Alert |
| 08/09/2022 | Buy Now | 72.41% | Needham | David Saxon54% | $28 → $24 | Maintains | Buy | Get Alert |
| 07/15/2022 | Buy Now | 29.31% | Morgan Stanley | Drew Ranieri45% | $22 → $18 | Maintains | Overweight | Get Alert |
| 05/10/2022 | Buy Now | 58.05% | Morgan Stanley | Drew Ranieri45% | $28 → $22 | Maintains | Overweight | Get Alert |
| 05/10/2022 | Buy Now | 101.15% | Needham | David Saxon54% | $30 → $28 | Maintains | Buy | Get Alert |
FAQ
What is the target price for SI-BONE (SIBN) stock?
The latest price target for SI-BONE (NASDAQ:SIBN) was reported by Citizens Capital Markets on February 25, 2025. The analyst firm set a price target for $32.00 expecting SIBN to rise to within 12 months (a possible 129.89% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for SI-BONE (SIBN)?
The latest analyst rating for SI-BONE (NASDAQ:SIBN) was provided by Citizens Capital Markets, and SI-BONE reiterated their market outperform rating.
When was the last upgrade for SI-BONE (SIBN)?
There is no last upgrade for SI-BONE
When was the last downgrade for SI-BONE (SIBN)?
There is no last downgrade for SI-BONE.
When is the next analyst rating going to be posted or updated for SI-BONE (SIBN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SI-BONE, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SI-BONE was filed on February 25, 2025 so you should expect the next rating to be made available sometime around February 25, 2026.
Is the Analyst Rating SI-BONE (SIBN) correct?
While ratings are subjective and will change, the latest SI-BONE (SIBN) rating was a reiterated with a price target of $32.00 to $32.00. The current price SI-BONE (SIBN) is trading at is $13.92, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
